BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu RJ, Zheng RJ, Huang YQ, Ma XD. [Chidamide combined with chemotherapy for treatment of therapy-related acute myeloid leukemia secondary to peripheral T-cell lymphoma: a case report and literatures review]. Zhonghua Xueye Xue Zazhi. 2019;40:685-687. [PMID: 31495139 DOI: 10.3760/cma.j.issn.0253-2727.2019.08.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Zheng J, Huo Q, Chen Z, Chen J, Xu X, Papaccio G. Chidamide Suppresses the Growth of Cholangiocarcinoma by Inhibiting HDAC3 and Promoting FOXO1 Acetylation. Stem Cells International 2022;2022:1-15. [DOI: 10.1155/2022/3632549] [Reference Citation Analysis]
2 Huang L, Meng C, Liu D, Fu XJ. Secondary peripheral T-cell lymphoma and acute myeloid leukemia after Burkitt lymphoma treatment: A case report. World J Clin Cases 2021; 9(24): 7237-7244 [PMID: 34540984 DOI: 10.12998/wjcc.v9.i24.7237] [Reference Citation Analysis]